Cetuximab

ATC L01FE01 · 11 markets · 18 records

Cetuximab 11 markets · 18 records Forms

AU 5 records · 4 strengths

100 mg/20 mLinjectionERBITUX also in GB·CN
500 mg/100 mLinjectionERBITUX also in GB
5 mg/mLinjectionERBITUX cetuximab (rmc) 100mg/20mL solution for intravenous infusion also in SG unknown

Records without a stated strength · 1 ERBITUX

GB 3 records · 3 strengths

100 mg/20 mLinjectionErbitux 100mg/50ml solution for infusion vials also in AU·CN
500 mg/100 mLinjectionErbitux 100mg/50ml solution for infusion vials also in AU
100 mg/50 mLinjectionErbitux 100mg/50ml solution for infusion vials

US 2 records · 1 strengths

2 mgliquidERBITUX also in CA

CA 1 records · 1 strengths

2 mgliquidERBITUX also in US

SG 1 records · 1 strengths

5 mg/mLinjectionErbitux 5mg/ml also in AU

CN 1 records · 1 strengths

100 mg/20 mLinjection爱必妥西妥昔单抗 also in AU·GB

ES 1 records · 1 strengths

5 mginjectionERBITUX also in TW

TW 1 records · 1 strengths

5 mginjectionErbitux 5mg/ml Solution for infusion+1爾必得舒注射液 5 毫克/毫升 also in ES

HK 1 records · 1 strengths

Records without a stated strength · 1 ERBITUX SOLN FOR INFUSION 5MG/ML

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 ERBITUX

Side-by-side table

Strength / form / release	US	GB	CA	AU	SG	CN	ES	TW	HK	EU
100 mg/20 mL injection	not recorded	Erbitux 100mg/50ml solution for infusion vials	not recorded	ERBITUX	not recorded	爱必妥西妥昔单抗	not recorded	not recorded	not recorded	not recorded
5 mg injection	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	ERBITUX	Erbitux 5mg/ml Solution for infusion 爾必得舒注射液 5 毫克/毫升	not recorded	not recorded
2 mg liquid	ERBITUX	not recorded	ERBITUX	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
500 mg/100 mL injection	not recorded	Erbitux 100mg/50ml solution for infusion vials	not recorded	ERBITUX	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
5 mg/mL injection	not recorded	not recorded	not recorded	ERBITUX cetuximab (rmc) 100mg/20mL solution for intravenous infusion	Erbitux 5mg/ml	not recorded	not recorded	not recorded	not recorded	not recorded
100 mg/50 mL injection	not recorded	Erbitux 100mg/50ml solution for infusion vials	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	ERBITUX	not recorded	not recorded	not recorded	not recorded	ERBITUX SOLN FOR INFUSION 5MG/ML	ERBITUX

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

1 more strength/form rows are recorded only in ES · TW and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en ES · TW que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 ES · TW 有记录（未在本表显示）。另有 1 個規格/劑型僅在 ES · TW 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.